Status:
COMPLETED
Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants
Lead Sponsor:
GlaxoSmithKline
Collaborating Sponsors:
Optum, Carolyn Martin and Ami Buikema
Conditions:
Diphtheria
Acellular Pertussis
Eligibility:
All Genders
Up to 1 years
Brief Summary
This study aims to estimate the risk factors associated with pertussis/whopping cough infection among infants less than one year of age in a United States (U.S.) commercially insured population. The s...
Detailed Description
This study will utilize the OptumInsight proprietary research database which contains enrollment and claims data for individuals enrolled in commercial health plans to estimate the measureable demogra...
Eligibility Criteria
Inclusion
- Date of birth between July 1, 2005 and September 30, 2010.
- Enrollment in a commercial health plan within one month of birth.
- Known sex and geographic region.
- Infants will be included as a pertussis/whooping cough case if they meet the diagnosis criteria Infants not identified as a pertussis/whooping cough case are eligible for inclusion as a control.
Exclusion
- • Enrollment does not include medical and pharmacy coverage.
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01890850
Start Date
July 1 2013
End Date
November 1 2013
Last Update
July 22 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.